相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autocrine activin A signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia
Kristine Pettersen et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Sarcopenia as a predictor of mortality in women with breast cancer: a meta-analysis and systematic review
Xiao-Ming Zhang et al.
BMC CANCER (2020)
The expression landscape of cachexia-inducing factors in human cancers
Paula Paccielli Freire et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia
Sara Chiappalupi et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
FoxO maintains a genuine muscle stem-cell quiescent state until geriatric age
Laura Garcia-Prat et al.
NATURE CELL BIOLOGY (2020)
Docosahexaenoic Acid, a Potential Treatment for Sarcopenia, Modulates the Ubiquitin-Proteasome and the Autophagy-Lysosome Systems
Jung Hoon Lee et al.
NUTRIENTS (2020)
The S100B story: from biomarker to active factor in neural injury
Fabrizio Michetti et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Mediators of cachexia in cancer patients
Josep M. Argiles et al.
NUTRITION (2019)
Circulating miR-203 derived from metastatic tissues promotes myopenia in colorectal cancer patients
Yoshinaga Okugawa et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Interleukin-8 enhances myocilin expression, Akt-FoxO3 signaling and myogenic differentiation in rat skeletal muscle cells
Marta Milewska et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial Function
Fabio Penna et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention
Chun-wei Li et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Tumor Transcriptome Reveals High Expression of IL-8 in Non-Small Cell Lung Cancer Patients with Low Pectoralis Muscle Area and Reduced Survival
Sarah Santiloni Cury et al.
CANCERS (2019)
Human Cachexia Induces Changes in Mitochondria, Autophagy and Apoptosis in the Skeletal Muscle
Gabriela S. de Castro et al.
CANCERS (2019)
Prognostic Significance of Sarcopenia and Systemic Inflammatory Response in Patients With Esophageal Cancer
Tomoyuki Matsunaga et al.
ANTICANCER RESEARCH (2019)
IL-8 Released from Human Pancreatic Cancer and Tumor-Associated Stromal Cells Signals through a CXCR2-ERK1/2 Axis to Induce Muscle Atrophy
Chandler S. Callaway et al.
CANCERS (2019)
Tumor-Derived Ligands Trigger Tumor Growth and Host Wasting via Differential MEK Activation
Wei Song et al.
DEVELOPMENTAL CELL (2019)
ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells
Jingxuan Yang et al.
GASTROENTEROLOGY (2019)
Close Relationship Between Immunological/Inflammatory Markers and Myopenia and Myosteatosis in Patients With Colorectal Cancer: A Propensity Score Matching Analysis
Yoshinaga Okugawa et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2019)
Sarcopenia associated with chemotherapy and targeted agents for cancer therapy
Mellar P. Davis et al.
ANNALS OF PALLIATIVE MEDICINE (2019)
Cancer cachexia is defined by an ongoing loss of skeletal muscle mass
Vickie E. Baracos et al.
ANNALS OF PALLIATIVE MEDICINE (2019)
Targeting RAGE Signaling in Inflammatory Disease
Barry I. Hudson et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
A cross-sectional study examining the prevalence of cachexia and areas of unmet need in patients with cancer
Ola Magne Vagnildhaug et al.
SUPPORTIVE CARE IN CANCER (2018)
Tumor-derived cytokines impair myogenesis and alter the skeletal muscle immune microenvironment
Kelly A. Hogan et al.
CYTOKINE (2018)
Cancer secretome and inflammation: The bright and the dark sides of NF-κB
Darla Capece et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naive pancreatic cancer patients
Erin E. Talbert et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia
Fabrizio Pin et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Myeloid cell-derived tumor necrosis factor-alpha promotes sarcopenia and regulates muscle cell fusion with aging muscle fibers
Ying Wang et al.
AGING CELL (2018)
Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma
Takayuki Nakayama et al.
CLINICAL GENITOURINARY CANCER (2018)
Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data
Guifang Guo et al.
PLOS ONE (2018)
Elevated Serum Interleukin-8 Level Correlates with Cancer-Related Cachexia and Sarcopenia: An Indicator for Pancreatic Cancer Outcomes
Ya-Chin Hou et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice
Susan C. Kandarian et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer
Keun Hur et al.
GUT (2017)
Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation
Yang Quan-Jun et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Differentiating Sarcopenia and Cachexia Among Patients With Cancer
Sarah J. Peterson et al.
NUTRITION IN CLINICAL PRACTICE (2017)
Anorexia-cachexia syndrome in hepatoma tumour-bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC-1/GDF15
Tito Borner et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Inflammation and sarcopenia: A systematic review and meta-analysis
Giulia Bano et al.
MATURITAS (2017)
Exercise interventions for individuals with advanced cancer: A systematic review
Kim L. Dittus et al.
PREVENTIVE MEDICINE (2017)
Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
Matthias Pinter et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90
Guohua Zhang et al.
NATURE COMMUNICATIONS (2017)
Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice
Jacob L. Brown et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling
Kristine Pettersen et al.
SCIENTIFIC REPORTS (2017)
Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy
Francesca Riuzzi et al.
SCIENTIFIC REPORTS (2017)
Skeletal muscle autophagy and its role in sarcopenia and organismal aging
Jianqin Jiao et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta-analysis
Ross D. Dolan et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Regulation of muscle growth and regeneration by the immune system
James G. Tidball
NATURE REVIEWS IMMUNOLOGY (2017)
Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and-2 agonist
Miriam Toledo et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment
Yuji Miyamoto et al.
CLINICAL CANCER RESEARCH (2016)
Muscle-specific microRNAs in skeletal muscle development
Martin Horak et al.
DEVELOPMENTAL BIOLOGY (2016)
Key determinants of energy expenditure in cancer and implications for clinical practice
S. A. Purcell et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2016)
High mTORC1 signaling is maintained, while protein degradation pathways are perturbed in old murine skeletal muscles in the fasted state
Zoe White et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting
Xiu-yan Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Autophagy maintains stemness by preventing senescence
Laura Garcia-Prat et al.
NATURE (2016)
Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value
Drazena Srdic et al.
SUPPORTIVE CARE IN CANCER (2016)
CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer
Makito Miyake et al.
NEOPLASIA (2016)
Voluntary resistance wheel exercise from mid-life prevents sarcopenia and increases markers of mitochondrial function and autophagy in muscles of old male and female C57BL/6J mice
Zoe White et al.
SKELETAL MUSCLE (2016)
Muscle wasting associated with the long-term use of mTOR inhibitors
Bishal Gyawali et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival
Amelia J. Johnston et al.
CELL (2015)
Systemic Organ Wasting Induced by Localized Expression of the Secreted Insulin/IGF Antagonist ImpL2
Young Kwon et al.
DEVELOPMENTAL CELL (2015)
A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia
Danielle N. Seto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Role of Activin A and Myostatin in Human Cancer Cachexia
Audrey Loumaye et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer
Zhengxiang Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Renin-Angiotensin System: An Old Player with Novel Functions in Skeletal Muscle
Claudio Cabello-Verrugio et al.
MEDICINAL RESEARCH REVIEWS (2015)
SKELETAL MUSCLE LOSS IS ASSOCIATED WITH TNF MEDIATED INSUFFICIENT SKELETAL MYOGENIC ACTIVATION AFTER BURN
Juquan Song et al.
SHOCK (2015)
Prognostic value of sarcopenia in liver surgery
M. Cornet et al.
JOURNAL OF VISCERAL SURGERY (2015)
Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma
Ya-Hsuan Chang et al.
SCIENTIFIC REPORTS (2015)
Exercise for cancer cachexia in adults: Executive summary of a Cochrane Collaboration systematic review
Antonio Jose Grande et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib
Frederick Moryoussef et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Sue C. Bodine et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Identification of prognostic inflammatory factors in colorectal liver metastases
Trevor D. Hamilton et al.
BMC CANCER (2014)
Cancer Usurps Skeletal Muscle as an Energy Repository
Yi Luo et al.
CANCER RESEARCH (2014)
Pharmacological Inhibition of Poly(ADP-Ribose) Polymerases Improves Fitness and Mitochondrial Function in Skeletal Muscle
Eija Pirinen et al.
CELL METABOLISM (2014)
Regulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program
Sajedah M. Hindi et al.
FASEB JOURNAL (2014)
Elevated expression of activins promotes muscle wasting and cachexia
Justin L. Chen et al.
FASEB JOURNAL (2014)
Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia
Serkan Kir et al.
NATURE (2014)
Cancer cachexia: understanding the molecular basis
Josep M. Argiles et al.
NATURE REVIEWS CANCER (2014)
Autophagic Degradation Contributes to Muscle Wasting in Cancer Cachexia
Fabio Penna et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy
Yi Luo et al.
EUROPEAN JOURNAL OF CANCER (2013)
Bladder cancer-induced skeletal muscle wasting: Disclosing the role of mitochondria plasticity
Ana Isabel Padrao et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Vascular Endothelial Growth Factor Induces CXCL1 Chemokine Release via JNK and PI-3K-Dependent Pathways in Human Lung Carcinoma Epithelial Cells
Huey-Ming Lo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia
Wei A. He et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Possible Role for Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia
Katsutoshi Ando et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Favorable Responses to Tocilizumab in Two Patients With Cancer-Related Cachexia
Haruhiko Hirata et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2013)
Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer
Jiang Wu et al.
NUTRITION (2013)
Highly Specific Detection of Myostatin Prodomain by an Immunoradiometric Sandwich Assay in Serum of Healthy Individuals and Patients
Astrid Breitbart et al.
PLOS ONE (2013)
HuR and miR-1192 regulate myogenesis by modulating the translation of HMGB1 mRNA
Virginie Dormoy-Raclet et al.
NATURE COMMUNICATIONS (2013)
JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia
Andrea Bonetto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma
C. M. M. Prado et al.
BRITISH JOURNAL OF CANCER (2012)
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Swarnali Acharyya et al.
CELL (2012)
Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?
Celena Scheede-Bergdahl et al.
CLINICAL NUTRITION (2012)
Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas
Hanna Lee et al.
PLOS ONE (2012)
Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance
Silvia Busquets et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2012)
IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the Apc>Min mouse
James P. White et al.
SKELETAL MUSCLE (2012)
Muscle oxidative capacity during IL-6-dependent cancer cachexia
James P. White et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis
Theodore P. Braun et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models
Stefano Schiaffino et al.
SKELETAL MUSCLE (2011)
IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression
Tadashi Yoshida et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+T cells and prognosis in patients with stage IIIB colon cancer
Rui-Qing Peng et al.
BMC CANCER (2010)
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Xiaolan Zhou et al.
CELL (2010)
HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer
Yi Luo et al.
EUROPEAN JOURNAL OF CANCER (2010)
FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy
Bin Zheng et al.
FASEB JOURNAL (2010)
Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial
Daniel A. Galvao et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study
Sami Antoun et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Association of Interleukin-8 Gene Polymorphism With Cachexia From Patients With Gastric Cancer
Song Bo et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer
R. Jing et al.
NEOPLASMA (2010)
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
Anne Ulrike Trendelenburg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
Carla M. M. Prado et al.
CLINICAL CANCER RESEARCH (2009)
Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: Relationship to acute phase response and survival
Alastair G. W. Moses et al.
ONCOLOGY REPORTS (2009)
Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer
Lukas A. Hefler et al.
CLINICAL CANCER RESEARCH (2008)
IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop
Hongxia Ren et al.
JOURNAL OF CELL BIOLOGY (2008)
Induction of MuRF1 Is Essential for TNF-α-Induced Loss of Muscle Function in Mice
Volker Adams et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Nuclear factor-kappa B signaling in skeletal muscle atrophy
Hong Li et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
Carla M. M. Prado et al.
LANCET ONCOLOGY (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
MicroRNAs flex their muscles
Eva van Rooij et al.
TRENDS IN GENETICS (2008)
Association of elevated C-reactive protein levels with an impaired prognosis in patients with surgically treated endometrial cancer
Maximilian Schmid et al.
OBSTETRICS AND GYNECOLOGY (2007)
FoxO3 controls autophagy in skeletal muscle in vivo
Cristina Mammucari et al.
CELL METABOLISM (2007)
FoxO3 coordinately activates protein degradation by the Autophagic/Lysosomal and proteasomal pathways in atrophying muscle cells
Jinghui Zhao et al.
CELL METABOLISM (2007)
C-reactive protein is a prognostic parameter in patients with cervical cancer
Stephan Polterauer et al.
GYNECOLOGIC ONCOLOGY (2007)
Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma
T. Sasahira et al.
HISTOPATHOLOGY (2007)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine
Charu Dogra et al.
FASEB JOURNAL (2007)
Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes - Evidence for tweak- independent functions of Fn14 during myogenesis
Charu Dogra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation
Helen L. Eley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A systematic review of the association between circulating concentrations of C reactive protein and cancer
Katriina Heikkila et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2007)
Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins
Yisrael Sidis et al.
ENDOCRINOLOGY (2006)
Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer
Asne R. Bauskin et al.
CANCER RESEARCH (2006)
Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-κB and degradation of MyoD protein
C Dogra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer
Gaetano Leto et al.
CLINICAL & EXPERIMENTAL METASTASIS (2006)
The neuroendocrine response to critical illness is a dynamic process
I Vanhorebeek et al.
CRITICAL CARE CLINICS (2006)
Tumor necrosis factor-α gene transfer induces cachexia and inhibits muscle regeneration
D Coletti et al.
GENESIS (2005)
The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma
K Hashimoto et al.
CANCER (2005)
Systemic inflammation, cachexia and prognosis in patients with cancer
C Deans et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2005)
Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas
NB Jamieson et al.
BRITISH JOURNAL OF CANCER (2005)
Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice
DAM Salih et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization
RCJ Langen et al.
FASEB JOURNAL (2004)
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products
S Acharyya et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma
R Hatpio et al.
CLINICAL BIOCHEMISTRY (2004)
Activin: an important regulator of wound repair, fibrosis, and neuroprotection
S Sulyok et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
The IGF-1/PI3K/Akt pathway prevents short article expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors
TN Stitt et al.
MOLECULAR CELL (2004)
Pleiotropic effects of CXC chemokines in gastric carcinoma:: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma
M Eck et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma
M Ikeda et al.
ANNALS OF SURGERY (2003)
IL-1β stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-κB
GJ Luo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum
JB Welsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Induction of cachexia in mice by systemically administered myostatin
TA Zimmers et al.
SCIENCE (2002)
Human C-reactive protein: expression, structure, and function
JE Volanakis
MOLECULAR IMMUNOLOGY (2001)
Longitudinal study of resting energy expenditure, body cell mass and the inflammatory response in male patients with non-small cell lung cancer
HR Scott et al.
LUNG CANCER (2001)
NF-κB-induced loss of MyoD messenger RNA:: Possible role in muscle decay and cachexia
DC Guttridge et al.
SCIENCE (2000)
分享论文
